Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-705-0 | CAS number: 98-83-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicity to reproduction
Administrative data
- Endpoint:
- two-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well reported study using recognised test methodology with detailed description of findings. Test material was a close chemical analogue of the registered substance
Data source
Reference
- Reference Type:
- publication
- Title:
- Two Generation Reproduction Study of Styrene by Inhalation in Crl-CD Rats
- Author:
- Cruzan G. et al
- Year:
- 2 005
- Bibliographic source:
- Birth Defects Research (Part B) 74:211–220
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)
- Principles of method if other than guideline:
- Although not stated in the published paper, test method was closely similar to OECD 416
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Styrene
- EC Number:
- 202-851-5
- EC Name:
- Styrene
- Cas Number:
- 100-42-5
- Molecular formula:
- C8H8
- IUPAC Name:
- styrene
- Test material form:
- other: vapour
- Details on test material:
- Styrene (CAS 100-42-5), purity 99.9% minimum (contained 10 ppm t-butylcatechol inhibitor)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD (SD)IGS BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Males 263-266g, females 189-190g at start of exposure. Caged (F0, F1 parents individually until pairing) in mesh-bottom cages, but mated femaled transferred to plastic-bottom cages. Food and water supplied ad lib, except during inhalation exposure.
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- air
- Details on exposure:
- Whole body vapour exposure, 6h/day for at least 70 days
- Details on mating procedure:
- Sexes paired 1:1 for up to 14 days; mating confirmed by plug or vaginal smear
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- GC analysis of chamber atmospheres
- Duration of treatment / exposure:
- F0 parents: 70 days; F0 and F1 females: exposure continued through mating and gestation to gestation day 20 but on lactation days 1-4 these females were dosed via oral gavage (66, 117, or 300 mg/kg/day, split into 3 equal doses ca. 2h apart). F1 pups: exposure started on postnatal day 22.
- Frequency of treatment:
- Daily (6h/day)
- Details on study schedule:
- Continuous exposure as detailed.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0 ppm
Basis:
nominal conc.
Mean measured 0 ppm
- Remarks:
- Doses / Concentrations:
50 ppm
Basis:
nominal conc.
mean measured F0 and F1 50 ppm/0.21 mg/l
- Remarks:
- Doses / Concentrations:
150 ppm
Basis:
nominal conc.
mean measured F0 151 ppm (0.64 mg/l), F1 153 ppm (0.65 mg/l)
- Remarks:
- Doses / Concentrations:
500 ppm
Basis:
nominal conc.
mean measured F0 499 ppm (2.12 mg/l), F1 501 ppm (2.13 mg/l)
- No. of animals per sex per dose:
- 25
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- Oral dosage given to F0 and F1 females (lactation days 1-4) was calculated to generate peak blood level equivalent to that during 6h inhalation exposure. Litters standardised (random selection to give 5M, 5F where possible) on postnatal day 4.
- Positive control:
- No
Examinations
- Parental animals: Observations and examinations:
- Twice daily observations of parents plus mid-point of exposure check in situ. Bodyweights and food consumption recorded weekly (females food and water consumption more frequently during gestation and lactation).
- Oestrous cyclicity (parental animals):
- Monitored by vaginal smears
- Sperm parameters (parental animals):
- At necropsy: right epididymides plus left testes with cauda epdidymides weighed, sperm morphology and motility assessed. Homogenisation-resistant sperm count and sperm production rate also determined
- Litter observations:
- Postnatal deaths necropsied up to weaning and postnatal days 22-28. Pups sexed and developmental milestones recorded.
Livebirth numbers and postnatal deaths were recorded, together with pup weights. - Postmortem examinations (parental animals):
- Ovarian sections collected from all F0 females; 5 ovarian sections from control and high-dose F1 females subjected to histopathological examination. Following complete necropsy investigations including organ weight recording, selected tissues taken for histopathology: microscopic examination applied to tissues from control and high-dose F0, F1 parents plus decedents from intermediate test groups
- Postmortem examinations (offspring):
- Gross abnormalities (internal or external) recorded at necropsy, with organ weights
- Statistics:
- Two-tailed tests compared each test group to control. Parental mating and fertility indices analysed by Chi-squared test with Yates' correction. Other parental and F2 progeny data were analysed for heterogeneity of variance and normality. If homogeneous and normal, parametric one-way analysis of variance was used to determine intergroup differences: then either Dunnett's test or the Kruskal-Wallis nonparametric test was applied to determine intergroup differences. TheMann Whitney U-test was used to compare test groups to the control where appropriate. Pup weights during weaning were analysed separately (nested analysis of covariance, by sex).
- Reproductive indices:
- Parameters examined: oestrous cycle length, male and female mating index, pre-coital interval, male and female fertility index, gestation length, pup number and sex, stillbirths, livebirths, postnatal mortalities, presence of gross anomalies, bodyweight gain, physical or behavioural abnormalities.
Reproductive indices: mating, fertility - Offspring viability indices:
- Livebirths, postnatal mortality
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Slightly reduced at 500 ppm in F0 males and females (premating weeks 3-10); reduced at 150 ppm in F0 males (gain during week 1 and in week 7) and F1 males/females ( postnatal days 22-27 and through F1 exposure).
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- Slightly reduced at 500 ppm in F0 males and females (premating weeks 3-10); reduced at 150 ppm in F0 males (gain during week 1 and in week 7) and F1 males/females ( postnatal days 22-27 and through F1 exposure).
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- Nasal olfactory epithelium degeneration at 500 ppm
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEC
- Effect level:
- 50 other: ppm mean measured concentration (0.21 mg/l)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Systemic toxicity: degeneration of nasal olfactory epithelium at 500 ppm. Reduced bodyweights (F0+F1 males, F1 females at 150 and 500 ppm), increased water consumption during lactation (F0 females, 150 and 500 ppm)
- Dose descriptor:
- NOAEC
- Effect level:
- 500 other: ppm mean measured concentration (2.1 mg/l)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Reproductive toxicity: no effects on fertility, reproductive organs or sperm, gestation, live litter size or postnatal survival seen at highest tested concentration
- Remarks on result:
- other: Generation: F0, F1 (migrated information)
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Mean F2 male/female birthweights and bodyweight gains during pre-weaning reduced
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- F2 male bodyweight-relative pituitary weights reduced at 500 ppm
- Gross pathological findings:
- no effects observed
Details on results (F1)
Effect levels (F1)
- Remarks on result:
- other: see text for details
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Although significant reductions in pituitary weight were seen at 500 ppm in F2 male pups and at 150 and 500 ppm in F2 females, only in F2 males at 500 ppm where bodyweight-relative pituitary weight reduction was also seen was a pituitary effect considered attributable to styrene exposure. The other cases, together with statistically significant decreases in mean thymus and uterine weights in F2 females at 500 ppm, were judged likely to be associated with growth retardation.
Applicant's summary and conclusion
- Conclusions:
- No significant effect on reproductive performance, or on morphology or function of reproductive organs, was seen when rats were exposed to styrene (6h/day over 2 generations) at concentrations up to 500 ppm (mean measured concentration: equal to 2.1 mg/l) in this study. A NOAEC value of 50 ppm/0.21 mg/l was concluded for systemic toxicity to the F0 and F1 parental generations , togther with a NOAEC value of 2.1 mg/l for toxicity to reproduction.
- Executive summary:
In this reliable study of styrene toxicity, no significant effect on reproductive performance, or on morphology or function of reproductive organs, was seen when rats were exposed to styrene (6h/dayover 2 generations) at concentrations up to 500 ppm (mean measured concentration: equal to 2.1 mg/l) in this study. A NOAEC value of 50 ppm/0.21 mg/l was concluded for systemic toxicity to the F0 and F1 parental generations, together with a NOAEC value of 2.1 mg/l for toxicity to reproduction. Based on the justification document supplied in section 13 of this dossier which supports the use of read-across from styrene to the registered substance 2-phenylpropene, it is concluded that these NOAEC values and the observed absence of toxicity to reproduction can reasonably be considered applicable to the registered substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Sellel veebilehel kasutatakse küpsiseid, et tagada lehe parim kasutus.